Terumo Interventional Systems – BSIR Glasgow 2021

Founded in Tokyo in 1921, Terumo is a multinational company with more than 90 years’ experience in developing best in class medical devices. At Terumo Interventional Systems, we constantly work to refine and perfect our products so that interventionists can do more.

Terumo offers intervention in all dimensions: from access to closure.

Our access portfolio consists of Radifocus Introducer II kits, Destination, guiding sheath and Radifocus Guidewire M developed to provide superior access the majority of cases. Peripheral diagnostic procedures can be performed with Radifocus Glidecath, a hydrophilic angiographic catheter. New for 2021, is an extended access portfolio for radial procedures.

In critical limb ischemia, accessing the lesion can be performed with Radifocus Glidewire Advantage and catheter NaviCross. Roadsaver, a stent with a double layer micromesh design, is indicated to treat carotid arterial atherosclerosis. A full range of PTA balloons are available for peripheral interventions including Over the Wire and Rapid Exchange: Metacross 035″, Crostella and  Senri 018″ and Tercross 014″.

In interventional oncology, Terumo offers a comprehensive portfolio ranging from access devices, such as Progreat microcatheter, GT Wire, Occlusafe balloon occlusion catheter, embolics including Azur, HydroPearl as well as loco-regional therapies such as LifePearl drug-eluting microspheres and QuiremSpheres Holmium radioembolisation spheres.

For closure, Terumo offers a comprehensive range of bio absorbable closure devices including Angioseal and Femoseal.

We look forward to seeing you at BSIR this year on the Terumo stand.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated BSIR conference page to find out more.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more